NL970043I2 - Esters van hexahydro-8-hydroxy-2,6-methano-2H-chinolizin-3(4H)-on en verwante verbindingen. - Google Patents

Esters van hexahydro-8-hydroxy-2,6-methano-2H-chinolizin-3(4H)-on en verwante verbindingen.

Info

Publication number
NL970043I2
NL970043I2 NL970043C NL970043C NL970043I2 NL 970043 I2 NL970043 I2 NL 970043I2 NL 970043 C NL970043 C NL 970043C NL 970043 C NL970043 C NL 970043C NL 970043 I2 NL970043 I2 NL 970043I2
Authority
NL
Netherlands
Prior art keywords
quinolizin
methano
hexahydro
hydroxy
esters
Prior art date
Application number
NL970043C
Other languages
English (en)
Other versions
NL970043I1 (nl
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of NL970043I1 publication Critical patent/NL970043I1/nl
Publication of NL970043I2 publication Critical patent/NL970043I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL970043C 1986-11-03 1997-12-17 Esters van hexahydro-8-hydroxy-2,6-methano-2H-chinolizin-3(4H)-on en verwante verbindingen. NL970043I2 (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92661986A 1986-11-03 1986-11-03

Publications (2)

Publication Number Publication Date
NL970043I1 NL970043I1 (nl) 1998-03-02
NL970043I2 true NL970043I2 (nl) 1998-10-01

Family

ID=25453460

Family Applications (1)

Application Number Title Priority Date Filing Date
NL970043C NL970043I2 (nl) 1986-11-03 1997-12-17 Esters van hexahydro-8-hydroxy-2,6-methano-2H-chinolizin-3(4H)-on en verwante verbindingen.

Country Status (21)

Country Link
EP (1) EP0266730B1 (nl)
JP (2) JP2542225B2 (nl)
KR (1) KR950011737B1 (nl)
CN (1) CN1021654C (nl)
AR (1) AR246264A1 (nl)
AT (1) ATE109779T1 (nl)
AU (1) AU600318B2 (nl)
CA (1) CA1329203C (nl)
DE (2) DE19775092I2 (nl)
DK (1) DK171116B1 (nl)
ES (1) ES2061469T3 (nl)
FI (1) FI87786C (nl)
HU (1) HU197008B (nl)
IE (1) IE63670B1 (nl)
IL (1) IL84309A (nl)
NL (1) NL970043I2 (nl)
NO (2) NO165922C (nl)
NZ (1) NZ222349A (nl)
PH (2) PH24664A (nl)
PT (1) PT86060B (nl)
ZA (1) ZA878096B (nl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0329932B1 (en) * 1988-02-23 1995-10-18 Merrell Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments
EP0329902A1 (en) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of psychosis
EP0329903A1 (en) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Use of quinolizinone and quinolizine derivatives in the manufacture of medicaments for the treatment of glaucoma
US5011846A (en) * 1988-02-23 1991-04-30 Merrell Dow Pharmaceuticals Inc. Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
EP0329905A1 (en) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for increasing gastric motility
EP0329904A1 (en) * 1988-02-23 1989-08-30 Merrell Dow Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of anxiety
EP0330788A1 (en) * 1988-03-01 1989-09-06 Merrell Dow Pharmaceuticals Inc. Use of quinolizine and quinolizinone derivatives in the manufacture of medicaments for the treatment of cardiac arrhythmia
ZA893008B (en) * 1988-04-29 1989-12-27 Merrell Dow Pharma Process for preparing indole-3-carboxylic acid esters of transhexahydro-8-hydroxy-2,6-methano-2h-quinolizin-3(4h)-one
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
EP0492020A1 (en) * 1990-12-21 1992-07-01 Merrell Dow Pharmaceuticals Inc. Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders
AR016162A1 (es) * 1997-12-17 2001-06-20 Biocryst Pharm Inc Compuestos ciclopentano y ciclopenteno sustituidos que son de utilidad como inhibidores de la neuraminidasa y composicion que los contiene.
CN100390172C (zh) * 2004-09-10 2008-05-28 成都欣捷高新技术开发有限公司 一种甲磺酸多拉司琼晶型及其制备方法
EP1819705A1 (de) * 2004-11-25 2007-08-22 Cilag Ltd. Verfahren zur herstellung von estern von hexahydro-8-hydroxy-2,6-methano-2h-chinolizin-3(4h)-on
DE602006003227D1 (de) * 2005-07-06 2008-11-27 Inke Sa Verfahren zur gewinnung der pharmazeutisch aktivendavon und verfahren zu deren gewinnung
ES2264901B1 (es) 2005-07-06 2007-12-01 Inke, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo, sus intermedios de sintesis y procedimiento para la obtencion de los mismos.
EP1968978A2 (en) * 2006-01-05 2008-09-17 Teva Gyogyszergyár Zártköruen Muködo Részvenytarsaság Forms of dolasetron mesylate and processes for their preparation
EP2060557B1 (en) 2007-11-13 2012-06-06 Inke, S.A. Intermediate compounds useful to prepare dolasetron
LT2432467T (lt) 2009-05-20 2018-04-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Serotonino 5-ht3 receptoriaus antagonistai, skirti panaudoti pažeidimų sukeltų vestibiuliarinių sutrikimų gydymui
EP2253316B1 (en) 2009-05-20 2013-08-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of an inner ear pathology with vestibular deficits
WO2017044693A1 (en) 2015-09-11 2017-03-16 Chase Pharmaceuticals Corporation Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous system
CN108976230A (zh) * 2018-06-18 2018-12-11 东莞市联洲知识产权运营管理有限公司 一种基于石墨烯活化制备甲磺酸多拉司琼关键中间体的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
CH664567A5 (de) * 1983-08-26 1988-03-15 Sandoz Ag Aromatische carbonsaeure- und sulfonsaeureester oder -amide.
ATE86110T1 (de) * 1984-12-20 1993-03-15 Sandoz Ag Behandlung von gastrointestinalkrankheiten durch anwendung von 5-ht3-antagonisten.

Also Published As

Publication number Publication date
PT86060A (en) 1987-12-01
IE872955L (en) 1988-05-03
NO165922B (no) 1991-01-21
IE63670B1 (en) 1995-05-31
DE3750359D1 (de) 1994-09-15
DK572887A (da) 1988-05-04
ATE109779T1 (de) 1994-08-15
NO874550D0 (no) 1987-11-02
EP0266730A1 (en) 1988-05-11
NO874550L (no) 1988-05-04
JPS63258476A (ja) 1988-10-25
FI87786B (fi) 1992-11-13
FI874768A0 (fi) 1987-10-29
DK572887D0 (da) 1987-11-02
CA1329203C (en) 1994-05-03
JPH0977769A (ja) 1997-03-25
AU600318B2 (en) 1990-08-09
DE3750359T2 (de) 1994-12-08
IL84309A (en) 1991-09-16
HUT45055A (en) 1988-05-30
KR950011737B1 (ko) 1995-10-09
HU197008B (en) 1989-02-28
NO1999020I1 (no) 1999-08-26
PH26261A (en) 1992-04-01
DE19775092I2 (de) 2001-11-22
ZA878096B (en) 1988-04-26
JP2542225B2 (ja) 1996-10-09
FI874768A (fi) 1988-05-04
AR246264A1 (es) 1994-07-29
NO165922C (no) 1991-05-02
JP2657267B2 (ja) 1997-09-24
FI87786C (fi) 1993-02-25
ES2061469T3 (es) 1994-12-16
DK171116B1 (da) 1996-06-17
KR880006240A (ko) 1988-07-22
AU8059687A (en) 1988-05-05
CN1021654C (zh) 1993-07-21
EP0266730B1 (en) 1994-08-10
PH24664A (en) 1990-09-07
NZ222349A (en) 1990-05-28
PT86060B (pt) 1990-07-31
NL970043I1 (nl) 1998-03-02
CN87107629A (zh) 1988-06-15

Similar Documents

Publication Publication Date Title
NL970043I2 (nl) Esters van hexahydro-8-hydroxy-2,6-methano-2H-chinolizin-3(4H)-on en verwante verbindingen.
DE3674906D1 (de) Selbstklemmende medizinische prothese und ihre herstellung.
PT85616A (de) Aryloxycarbonsaurederivate ihre herstellung und verwendung
DE3885534D1 (de) Arylphosphorderivate, ihre Herstellung und Verwendung.
ATE87927T1 (de) Demethylavermectine und herstellung dazu.
MX9203134A (es) Esteres de hexahidro-8-hidroxi-2,6-metano-2h-quinolizin-3-(4h)-ona y compuestos relacionados.
NO882762D0 (no) Fremgangsmaate for fremstilling av antihypertensive og antiarytmiske forbindelser.
FI873398A0 (fi) Bestaemning av kliniska parametrar med hjaelp av en enzymatisk immunoprocess.
DE3888466D1 (de) 6-Arylaminomethylchinolin-Derivate und ihre Verwendung als Antitumorwirkstoff.
FI882583A0 (fi) Foerfarande foer tryckning pao plastunderlag med anvaendning av vattenbaserat blaeck.
NO870126D0 (no) 7-(azabicykloalkyl)-chinolinkarboksylsyre- og naftyri-donkarboksylsyre-derivater.
DE3781574T2 (de) Calixaren-derivate und die verwendung dieser verbindungen zur sequestrierung von metallen.
DE3789963D1 (de) Menschliche tachykinine und ihre vorläufer.
DE3783751T2 (de) Glyzirrhetinsaeure-derivate und ihre anwendung.
EP0311634A4 (en) 6- (6-ALKYLPYRIDONE) -CARBOSTYRILE COMPOUNDS AND THEIR CARDIOTONIC USES.
DE3889644D1 (de) Pheophorbidderivate.
NO863113D0 (no) Fremgangsmaate for fremstilling av heterocyclocarbonyl- og acetyl-thiazoloner.
FI861641A0 (fi) Foerfarande foer framstaellning av (-)-1 -etyl-1 -hydroximetyl-1,2,3,4,6,7,12,12b -oktahydroindolo/2,3-a/ -kinolizin.
NO871477D0 (no) Fremgangsmaate for fremstilling av human plasminogenaktivator.
DE3689036T2 (de) Lankacidinderivate und ihre Herstellung.
TR24449A (tr) Tiyazinol tuerevleri hazirlanmalarina mahsus usul v ve fungusid olarak kullanimi
NO870828D0 (no) Fremgangsmaate for fremstilling av biskarbamater.
FI900835A0 (fi) Taetning med reglerbar diameter.
DE3773736D1 (de) Mono-tertiaere-alkyl-toluoldiisocyanate und derivate.
PT85600A (de) 3-brom-2,6-dimethoxibenzamide ihre herstellung und verwendung